4//SEC Filing
Juno Therapeutics, Inc. 4
Accession 0001209191-16-129048
CIK 0001594864operating
Filed
Jun 20, 8:00 PM ET
Accepted
Jun 21, 4:36 PM ET
Size
6.8 KB
Accession
0001209191-16-129048
Insider Transaction Report
Form 4
Levitsky Hyam
See Remarks
Transactions
- Sale
Common Stock
2016-06-17$42.76/sh−12,118$518,121→ 117,000 total - Sale
Common Stock
2016-06-17$43.20/sh−300$12,960→ 116,700 total
Footnotes (2)
- [F1]This transaction was executed in multiple trades at prices ranging from $42.195 to $43.18. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- [F2]The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 16, 2016.
Documents
Issuer
Juno Therapeutics, Inc.
CIK 0001594864
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001594864
Filing Metadata
- Form type
- 4
- Filed
- Jun 20, 8:00 PM ET
- Accepted
- Jun 21, 4:36 PM ET
- Size
- 6.8 KB